The safety and tolerability of clozapine in aged patients: A retrospective clinical file review

World Journal of Biological Psychiatry

Volumn 11, Issue 6, 2010, Pages 788-791

  O'Connor, Daniel W ^a   Sierakowski, Christine ^b   Chin, Loi Fei ^c   Singh, Dhiren ^a,d  

^a MONASH UNIVERSITY   (Australia)

^b Caulfield Hospital   (Australia)

^c Southern Health   (Australia)

^d FRANKSTON HOSPITAL   (Australia)

Author keywords

Antipsychotics; Clozapine; Old age psychiatry; Psychopharmacology; Treatment

Indexed keywords

CLOZAPINE;

AGED; ATAXIA; BIPOLAR DISORDER; CARDIOMYOPATHY; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSLIPIDEMIA; DYSPHAGIA; ELECTROCARDIOGRAM; FEMALE; FEVER; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; PSYCHOPHARMACOLOGY; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SENESCENCE; SIDE EFFECT; STROKE; TACHYCARDIA;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; AUSTRALIA; CLOZAPINE; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LEUKOPENIA; MALE; PATIENT SATISFACTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77955628908     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.488273     Document Type: Review

References (24)

1. Alvir MJ, Liberman JA. 1994. Agranulocytosis: incidence and risk factors. J Clin Psychiatry 55 (suppl B): 137-138.
2. Barak Y, Wittenberg N, Naor S, Kutzuk D, Weizman A. 1999. Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy. Compr Psychiatry 40:320-325.
3. Ciapparelli A, Dell'Osso L, Pini S, Chiavacci MC, Fenzi M, Cassano GB. 2000. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study. J Clin Psychiatry 61: 329-334.
4. Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. 2000. Orthostatic hypotension as a risk factor for stroke: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1996. Stroke 31:2307-2313.
5. Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, et al. 2005. Clozapine, diabetes mellitus, hyper-lipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry 66:1116-1121.
6. Herst L, Powell G. 1997. Is Clozapine safe in the elderly? Austr NZ J Psychiatry 31:411-417.
7. Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J. 1998. Reducing Clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. J Clin Psychiatry 59 (suppl 3), 3-7.
8. Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N, Losonczy MF. 1999. The efficacy and safety of Clozapine versus Chlorpromazine in geriatric schizophrenia. J Clin Psychiatry 60:41-44.
9. Kilian JG, Kerr K, Lawrence C, Celermajer DS. 1999. Myocarditis and cardiomyopathy associated with Clozapine. Lancet 354:1841-1845.
10. Lee HB, Hanner JA, Yokley JL, Appleby B, Hurowitz L, Lyketsos CG. 2007. Clozapine for treatment-resistant agitation in dementia. J Geriatr Psychiatry Neurol 20:178-182.
11. Lieberman JA. 1998. Maximising Clozapine therapy: managing side effects. J Clin Psychiatry 59(suppl 3):38-43.
12. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209-1223.
13. Low PA. 2008. Prevalence of orthostatic hypotension. Clin Auton Res 18(suppl 1):8-13.
14. McCarthy R, Terkelsen KG. 1994. Esophageal dysfunction in two patients after Clozapine treatment. J Clin Psychopharmacol 14: 281-282
15. MacGillivray S, Cooper SJ, English B, Williams B, Millar H. 2003. Predictors of discontinuation on Clozapine: a population study. Ir J Psychol Med 20:115-118.
16. Miller DD. 2000. Review and management of Clozapine side effects. J Clin Psychiatry 61(suppl 8):14-17.
17. Novartis Pharmaceuticals. 2002. Clozaril Patient Monitoring System Protocol. Australia, Novartis Pharmaceuticals Australia.
18. Oberholzer AF, Hendriksen C, Monsch AU, Heierli B, Stähelin HB. 1992. Safety and effectiveness of low-dose Clozapine in psychogeriatric patients: a preliminary study. Int Psychogeriatr 4:187-195.
19. Paranthaman R, Baldwin RC. 2006. Survey of Clozapine use by consultant old age psychiatrists. Psychiatr Bull 30: 410-412.
20. Pearlman C. 1994. Clozapine, nocturnal sialorrhea, and choking. J Clin Psychopharmacol 14:283.
21. Salganik I, Modai J, Bercovici BR, Kutzuk D, Weizman A. 1998. Clozapine versus haloperidol therapy in elderly chronic schizophrenic inpatients- preliminary results. A double-blind, crossover randomised study. Int J Geriatr Psychopharmacol 1: 185-187.
22. Schindler JS, Kelly JH. 2002. Swallowing disorders in the elderly. Laryngoscope 112:589-602.
23. Stahl SS. 2000. Essential Pharmacology: Neuroscientific Basis and Practical Applications, 2nd ed. Cambridge, Cambridge University Press, p432.
24. Wahlbeck K, Cheine M, Essali A, Adams C. 1999. Evidence of Clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Arch Gen Psych 156: 990-999.